What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2024-08-12 compared with 2024-05-10 · 690 added, 414 removed, 120 unchanged (90% of the section changed)

Discussion and Analysis of Financial Condition and Results of Operations Cautionary Notice Regarding Forward-Looking Statements

The following discussion of the financial condition and results

of operations of the Company for the periods ended March 31, 2024 and 2023 should be read in conjunction with the financial statements

and the notes to the financial statements that are included elsewhere in this quarterly report.

In this quarterly report, references to “the Company,”

“we,” “our” and “us” refer to IT Tech Packaging, Inc.

and its PRC subsidiary and variable interest

entity unless the context requires otherwise.

We make certain forward-looking

statements in this report.

Statements concerning our future operations, prospects, strategies, financial condition, future economic performance

(including growth and earnings), demand for our products, and other statements of our plans, beliefs, or expectations, including the statements

contained under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations”

as well as captions elsewhere in this document, are forward-looking statements.

In some cases these statements are identifiable through

the use of words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”,

“plan”, “project”, “target”, “can”, “could”, “may”, “should”,

“will”, “would”, and similar expressions.

We intend such forward-looking statements to be covered by the safe

harbor provisions contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and in Section

21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The forward-looking statements we make are not

guarantees of future performance and are subject to various assumptions, risks, and other factors that could cause actual results to differ

materially from those suggested by these forward-looking statements.

Because such statements are subject to risks and uncertainties, actual

results may differ materially from those expressed or implied by the forward-looking statements.

Indeed, it is likely that some of our

assumptions may prove to be incorrect.

Our actual results and financial position may vary from those projected or implied in the forward-looking

statements and the variances may be material.

Management’s Discussion and Analysis

of Financial Condition and Results of Operations Cautionary Notice Regarding Forward-Looking Statements

The following discussion of the financial condition

and results of operations of the Company for the periods ended June 30, 2024 and 2023 should be read in conjunction with the financial

statements and the notes to the financial statements that are included elsewhere in this quarterly report.

In this quarterly report, references to “the

Company,” “we,” “our” and “us” refer to IT Tech Packaging, Inc.

and its PRC subsidiary and variable

interest entity unless the context requires otherwise.

We make certain forward-looking statements in

Statements concerning our future operations, prospects, strategies, financial condition, future economic performance (including

growth and earnings), demand for our products, and other statements of our plans, beliefs, or expectations, including the statements contained

under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as

captions elsewhere in this document, are forward-looking statements.

In some cases these statements are identifiable through the use of

words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, “plan”,

“project”, “target”, “can”, “could”, “may”, “should”, “will”,

“would”, and similar expressions.

We intend such forward-looking statements to be covered by the safe harbor provisions contained

in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and in Section 21E of the Securities Exchange

Act of 1934, as amended (the “Exchange Act”).

The forward-looking statements we make are not guarantees of future performance

and are subject to various assumptions, risks, and other factors that could cause actual results to differ materially from those suggested

by these forward-looking statements.

Because such statements are subject to risks and uncertainties, actual results may differ materially

from those expressed or implied by the forward-looking statements.

Indeed, it is likely that some of our assumptions may prove to be incorrect.

Our actual results and financial position may vary from those projected or implied in the forward-looking statements and the variances

may be material.

You are cautioned not to place undue reliance on such forward-looking statements.

risks and uncertainties, together with the other risks described from time to time in reports and documents that we file with the Securities

and Exchange Commission (the “SEC”) should be considered in evaluating forward-looking statements.

In evaluating the forward-looking

statements contained in this report, you should consider various factors, including, without limitation, the following:

(a) those risks

and uncertainties related to general economic conditions, (b) whether we are able to manage our planned growth efficiently and operate

profitably, (c) whether we are able to generate sufficient revenues or obtain financing to sustain and grow our operations, and (d) whether

we are able to successfully fulfill our primary requirements for cash.

We assume no obligation to update forward-looking statements, except

as otherwise required under federal securities laws.

These risks and uncertainties, together

with the other risks described from time to time in reports and documents that we file with the Securities and Exchange Commission (the

“SEC”) should be considered in evaluating forward-looking statements.

In evaluating the forward-looking statements contained

in this report, you should consider various factors, including, without limitation, the following:

(a) those risks and uncertainties related

to general economic conditions, (b) whether we are able to manage our planned growth efficiently and operate profitably, (c) whether we

are able to generate sufficient revenues or obtain financing to sustain and grow our operations, and (d) whether we are able to successfully

fulfill our primary requirements for cash.

We assume no obligation to update forward-looking statements, except as otherwise required

under federal securities laws.

Results of Operations

Comparison of the Three months ended March 31,

2024 and 2023

Revenue for the three months ended

March 31, 2024 was $6,863,841, representing a decrease of $12,927,036, or 65.32%, from $19,790,877 for the same period in the previous

This was mainly due to the production suspension of corrugating medium paper (“CMP”) in January and February of 2024,

and production suspension of tissue paper products in the first quarter of 2024.

Comparison of the Three months ended June 30, 2024 and 2023

Revenue for the three months ended June 30, 2024

was $26,249,788, a decrease of $3,770,126, or 12.56%, from $30,019,914 for the same period in the previous year.

This was mainly due to

the production suspension of offset printing paper and tissue paper products in the second quarter of 2024.

Revenue of Offset Printing Paper, Corrugating Medium Paper

and Tissue Paper Products

sales of offset printing paper, CMP and tissue paper products for the three months ended March 31, 2024 was $6,826,800, representing a

decrease of $12,924,348, or 65.44%, from $19,751,148 for the first quarter of 2023.

Total offset printing paper, CMP and tissue paper

products sold during the three months ended March 31, 2024 amounted to 18,670 tonnes, representing a decrease of 31,203 tonnes, or 62.56%,

compared to 49,873 tonnes sold in the comparable period in the previous year.

Production orders of CMP were arranged ahead of schedule

(in December 2023), in order to mitigate the impact of energy price rise in 2024.

Production of CMP was suspended in January and February

2024 due to the change of production schedule and Chinese New Year holiday.

Production of CMP was resumed in mid of March 2024.

of offset printing paper and tissue paper products were suspended due to the higher natural gas price and Chinese New Year in the first

quarter of 2024 and expected to resume in the third quarter of 2024.

The changes in revenue dollar amount and in quantity sold for the

three months ended March 31, 2024 and 2023 are summarized as follows:

Revenue from sales of offset

printing paper, corrugating medium paper (“CMP”) and tissue paper products for the three months ended June 30, 2024 was $26,212,815,

representing a decrease of $3,762,919, or 12.55%, from $29,975,734 for the second quarter of 2023.

Total offset printing paper, CMP and

tissue paper products sold during the three months ended June 30, 2024 amounted to 75,365 tonnes, representing a decrease of 3,271 tonnes,

or 4.16%, compared to 78,636 tonnes sold in the comparable period in the previous year.

Production of offset printing paper and tissue

paper products was suspended due to the rising natural gas prices in the first half of 2024.

It is expected that production will resume

in the third quarter of 2024.

The changes in revenue dollar amount and in quantity sold for the three months ended June 30, 2024 and 2023

are summarized as follows:

Three Months Ended

March 31, 2024

March 31, 2023

June 30, 2024

June 30, 2023

Sales Revenue

$ (10,717,368 )

Quantity (Tonne)

Light-Weight CMP

$ (1,984,027 )

$ (12,701,395 )

Offset Printing Paper

$ (3,155,882 )

Tissue Paper Products

Total CMP, Offset Printing Paper and Tissue Paper Revenue

Offset Printing Paper and Tissue Paper Revenue

$ (3,762,919 )

Monthly sales revenue for the 24 months ended March 31,

2024, are summarized below:

The Average Selling Prices (ASPs) for our main products in

the three months ended March 31, 2024 and 2023 are summarized as follows:

Three Months ended March 31, 2024

Three Months ended March 31, 2023

Monthly sales revenue for the 24 months ended June 30, 2024, are summarized

The Average Selling Prices (ASPs) for our main

products in the three months ended June 30, 2024 and 2023 are summarized as follows:

Offset Printing Paper ASP

Light-Weight CMP ASP

Tissue Paper Products ASP

Three Months ended June 30, 2024

Three Months ended June 30, 2023

Decrease from comparable period in the previous year

Decrease by percentage

The following chart shows the month-by-month ASPs for the

24-month period ended March 31, 2024:

The following chart shows the month-by-month ASPs for the 24-month

period ended June 30, 2024:

Corrugating Medium Paper

CMP amounted to $6,826,800 (100.00% of the total offset printing paper, CMP and tissue paper products revenues) for the three months ended

March 31, 2024, representing a decrease of $12,701,395, or 65.04%, from $19,528,195 for the comparable period in 2023.

Production of CMP

was suspended in January and February of 2024 and production of offset printing paper was suspended in the first quarter of 2024.

We sold 18,670 tonnes of CMP in

the three months ended March 31, 2024 as compared to 49,682 tonnes for the same period in 2023, representing a 62.42% decrease in quantity

ASP for regular CMP decreased from

$395/tonne for the three months ended March 31, 2023 to $368/tonne for the three months ended March 31, 2024, representing a 6.84% decrease.

ASP in RMB for regular CMP for the first quarter of 2023 and 2024 was RMB2,712 and RMB2,611, respectively, representing a 3.73% decrease.

The quantity of regular CMP sold decreased by 26,023 tonnes, from 41,663 tonnes in the first quarter of 2023 to 15,640 tonnes in the first

Revenue from CMP amounted

to $26,212,815 (100.00% of the total offset printing paper, CMP and tissue paper products revenues) for the three months ended June 30,

2024, representing a decrease of $262,705, or 0.99%, from $26,475,520 for the comparable period in 2023.

Production of offset printing

paper and tissue paper products was suspended in the second quarter of 2024.

We sold 75,365 tonnes of CMP in the three months ended June 30, 2024

as compared to 72,940 tonnes for the same period in 2023, representing a 3.32% increase in quantity sold.

ASP for regular CMP decreased from $365/tonne

for the three months ended June 30, 2023 to $350/tonne for the three months ended June 30, 2024, representing a 4.11% decrease.

RMB for regular CMP for the second quarter of 2023 and 2024 was RMB2,574 and RMB2,488, respectively, representing a 3.35% decrease.

quantity of regular CMP sold increased by 2,750 tonnes, from 60,063 tonnes in the second quarter of 2023 to 62,813 tonnes in the second

quarter of 2024.

ASP for light-weight CMP decreased

from $382/tonne for the three months ended March 31, 2023 to $355/tonne for the three months ended March 31, 2024, representing a 7.07%

ASP in RMB for light-weight CMP for the first quarter of 2023 and 2024 was RMB2,618 and RMB2,522, respectively, representing

a 3.68% decrease.

The quantity of light-weight CMP sold decreased by 4,989 tonnes, from 8,019 tonnes in the first quarter of 2023, to

3,030 tonnes in the first quarter of 2024.

Our PM6 production line, which produces

regular CMP, has a designated capacity of 360,000 tonnes /year.

The utilization rates for the first quarter of 2024 and 2023 were 15.11%

and 44.49%, respectively, representing a decrease of 29.38%.

Quantities sold for regular CMP that was produced by the

PM6 production line from April 2022 to March 2024 are as follows:

Our PM6 production line, which produces regular

CMP, has a designated capacity of 360,000 tonnes /year.

The utilization rates for the second quarter of 2024 and 2023 were 68.02% and

66.61%, respectively, representing an increase of 1.41%.

Quantities sold for regular CMP that was produced by the PM6

production line from July 2022 to June 2024 are as follows:

Offset printing paper

Revenue from offset printing paper was $nil for the three

months ended March 31, 2024 and 2023.

Production of offset printing paper was suspended in the three months ended March 31, 2024 and 2023.

Revenue from offset printing paper was $nil for

the three months ended June 30, 2024, representing a decrease of $3,155,882, or 100.00%, from $3,155,882 for the three months ended June

Production of offset printing paper was suspended during the second quarter of 2024.

Tissue Paper Products

Revenue from tissue paper products

was $nil and $222,953 for the three months ended March 31, 2024 and 2023, respectively.

Production of tissue paper products was suspended

during the first quarter of 2024.

Revenue from tissue paper products was $nil for

the three months ended June 30, 2024, representing a decrease of $344,332, or 100.00%, from $344,332 for the three months ended June 30,

Production of tissue paper products was suspended during the second quarter of 2024.

Revenue of Face Mask

Revenue generated from selling

face mask were $nil and $35,637 for the three months ended March 31, 2024 and 2023, respectively.

Revenue generated from selling face mask were

$nil and $44,246 for the three months ended June 30, 2024 and 2023, respectively.

Cost of Sales

Total cost of sales for CMP, offset

printing paper and tissue paper products for the quarter ended March 31, 2024 was $6,464,464, a decrease of $13,553,915, or 67.71%, from

$20,018,379 for the comparable period in 2023.

This was mainly due to the decrease in sales quantity and the decrease in the unit material

costs of CMP.

Cost of sales for CMP was $6,464,464

for the quarter ended March 31, 2024, as compared to $19,089,115 for the comparable period in 2023.

The decrease in the cost of sales

of $12,624,651 for CMP was mainly due to the decreases in sales volume and average unit cost of sales of CMP.

Average cost of sales per

tonne for CMP decreased by 9.90%, from $384 in the first quarter of 2023 to $346 in the first quarter of 2024.

The decrease in average

cost of sales was mainly attributable to the lower average unit purchase costs (net of applicable value added tax) of recycled paper board

in the first quarter of 2024 compared to the first quarter of 2023.

Cost of sales for tissue paper products

was $nil for the quarter ended March 31, 2024, as compared to $929,264 for the comparable period in 2023.

The production of tissue paper

products was suspended in the first quarter of 2024.

Changes in cost of sales and cost per tonne by product for

the quarters ended March 31, 2024 and 2023 are summarized below:

Total cost of sales for CMP, offset printing paper

and tissue paper products for the quarter ended June 30, 2024 was $22,984,488, a decrease of $5,807,701, or 20.17%, from $28,792,189 for

the comparable period in 2023.

This was mainly due to the decrease in sales quantity of offset printing paper and tissue paper products

and the decrease of the unit material cost of CMP products.

Cost of sales for CMP was $22,984,488 for the quarter ended June 30,

2024, as compared to $24,658,830 for the comparable period in 2023.

The decrease in the cost of sales of $1,674,342 for CMP was mainly

due to the decrease in average unit cost of sales of CMP, partially offset by the increase in sales volume of regular CMP.

of sales per tonne for CMP decreased by 9.76%, from $338 in the second quarter of 2023 to $305 in the second quarter of 2024.

in average cost of sales was mainly attributable to the lower average unit purchase costs (net of applicable value added tax) of recycled

paper board in the second quarter of 2024 compared to the second quarter of 2023.

Cost of sales for offset printing paper was $nil for the quarter ended

June 30, 2024, as compared to $3,079,485 for the comparable period in 2023.

The production of offset printing paper was suspended in the

second quarter of 2024.

Cost of sales for tissue paper products was $nil for the quarter ended

June 30, 2024, as compared to $1,053,874 for the comparable period in 2023.

The production of tissue paper products was suspended in the

second quarter of 2024.

Changes in cost of sales and cost per tonne by product for the quarters

ended June 30, 2024 and 2023 are summarized below:

Three Months Ended

March 31, 2024

March 31, 2023

Change in percentage

June 30, 2024

June 30, 2023

Cost of Sales

Cost per Tonne

Cost of Sales

Cost per Tonne

Cost of Sales

Cost per Tonne

Cost of Sales

Cost per Tone

$ (1,141,211 )

1 unchanged sentence

$ (1,674,342 )

$ (12,624,651 )

Offset Printing Paper

$ (3,079,485 )

Tissue Paper Products

$ (1,053,874 )

Total CMP, Offset Printing Paper and Tissue Paper

$ (5,807,701 )

Our average unit purchase costs (net of applicable value

added tax) of recycled paper board in the three months ended March 31, 2024 was RMB 1,276/tonne (approximately $180/tonne), as compared

to RMB 1,502/tonne (approximately $219/tonne) for the three months ended March 31, 2023.

These changes (in US dollars) represent a year-over-year

decrease of 17.81% for the recycled paper board.

We use domestic recycled paper (sourced mainly from the Beijing-Tianjin metropolitan

area) exclusively.

Although we do not rely on imported recycled paper, the pricing of which tends to be more volatile than domestic recycled

paper, our experience suggests that the pricing of domestic recycled paper bears some correlation to the pricing of imported recycled

The pricing trends of our major raw

materials for the 24-month period from April 2022 to March 2024 are shown below:

and gas are our two main energy sources.

Electricity and gas accounted for approximately 4% and 12.4% of total sales in the first quarter

of 2024, respectively, compared to 4% and 14% of total sales in the first quarter of 2023.

The monthly energy cost as a percentage of

total monthly sales of our main paper products for the 24 months ended March 31, 2024 are summarized as follows:

Our average unit purchase costs (net of applicable value added tax)

of recycled paper board in the three months ended June 30, 2024 were RMB 1,167/tonne (approximately $164/tonne), as compared to RMB 1,340/tonne

(approximately $192/tonne) for the three months ended June 30, 2023.

These changes (in US dollars) represent a year-over-year decrease

of 14.58% for the recycled paper board.

We use domestic recycled paper (sourced mainly from the Beijing-Tianjin metropolitan area) exclusively.

Although we do not rely on imported recycled paper, the pricing of which tends to be more volatile than domestic recycled paper, our experience

suggests that the pricing of domestic recycled paper bears some correlation to the pricing of imported recycled paper.

The pricing trends of our major raw materials

for the 24-month period from July 2022 to June 2024 are shown below:

Electricity and gas are

our two main energy sources.

Electricity and gas accounted for approximately 5% and 12.9% of total sales in the second quarter of 2024,

respectively, compared to 5% and 14.9% of total sales in the second quarter of 2023.

The monthly energy cost as a percentage of total

monthly sales of our main paper products for the 24 months ended June 30, 2024 are summarized as follows:

Gross Profit (Loss)

Gross profit for the three months ended March 31, 2024

was $399,113 (representing 5.81% of the total revenue), representing an increase of $676,112, or 244.08%, from the gross loss of $276,999

(representing 1.40% of the total revenue) for the three months ended March 31, 2023.

Gross profit for the three months ended June 30,

2024 was $3,265,300 (representing 12.44% of the total revenue), representing an increase of $2,085,442, or 176.75%, from the gross profit

of $1,179,858 (representing 3.93% of the total revenue) for the three months ended June 30, 2023, as a result of factors described above.

Offset Printing Paper, CMP and Tissue Paper Products

for offset printing paper, CMP and tissue paper products for the three months ended March 31, 2024 was $362,336, representing an increase

of $629,567, or 235.59%, from the gross loss of $267,231 for the three months ended March 31, 2023.

This was mainly due to the gross loss

incurred for tissue paper products in the first quarter of 2023.

The overall gross profit margin

for offset printing paper, CMP and tissue paper products increased by 6.66 percentage points, from -1.35% for the three months ended March

31, 2023, to 5.31% for the three months ended March 31, 2024.

Gross profit margin for regular

CMP for the three months ended March 31, 2024 was 5.68%, or 3.75 percentage points higher, as compared to gross profit margin of 1.93%

for the three months ended March 31, 2023.

Such increase was mainly due to the decrease in cost of recycled paper board, partially offset

by the decrease in ASP of regular CMP in the first quarter of 2024.

Gross profit margin for light-weight

CMP for the three months ended March 31, 2024 was 3.32%, or 0.64 percentage points lower, as compared to gross profit margin of 3.96%

for the three months ended March 31, 2023.

Monthly gross profit margins on the sales of our CMP and

offset printing paper for the 24-month period ended March 31, 2024 are as follows:

Gross loss for face masks for the three months ended March

31, 2024 and 2023 were gross loss of $nil and $2,839, respectively.

Gross profit for offset

printing paper, CMP and tissue paper products for the three months ended June 30, 2024 was $3,228,327, representing an increase of $2,044,782,

or 172.77%, from the gross profit of $1,183,544 for the three months ended June 30, 2023.

The increase was mainly the result of the factors

discussed above.

The overall gross profit margin for offset printing

paper, CMP and tissue paper products increased by 8.37 percentage points, from 3.95% for the three months ended June 30, 2023, to 12.32%

for the three months ended June 30, 2024.

Gross profit margin for regular CMP for the three

months ended June 30, 2024 was 12.22%, or 5.41 percentage points higher, as compared to gross profit margin of 6.81% for the three months

ended June 30, 2023.

Such increase was mainly due to the decrease in cost of recycled paper board, partially offset by the decrease in

ASP of regular CMP in the second quarter of 2024.

Gross profit margin for light-weight CMP for the

three months ended June 30, 2024 was 12.82%, or 5.68 percentage points higher, as compared to gross profit margin of 7.14% for the three

months ended June 30, 2023.

The increase was mainly due to the decrease in cost of recycled paper board, partially offset by the decrease

of ASP of light-weight CMP in the second quarter of 2024.

Monthly gross profit margins on the sales of our

CMP and offset printing paper for the 24-month period ended June 30, 2024 are as follows:

Gross loss for face masks for the three months

ended June 30, 2024 and 2023 were $nil and $3,568.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the

three months ended March 31, 2024 were $3,900,783, an increase of $1,405,421, or 56.32% from $2,495,362 for the three months ended March

The decrease was mainly due to the increase in depreciation of idle fixed assets during production suspension.

Loss from Operations

Operating loss for the quarter ended

March 31, 2024 was $3,501,670, a decrease of $729,309, or 26.31%, from $2,772,361 for the quarter ended March 31, 2023.

The decrease in

loss from operations was primarily due to the increase in selling, general and administrative expenses, partially offset by the increase

in gross profit.

Selling, general and administrative expenses for

the three months ended June 30, 2024 were $2,717,548, an increase of $1,394,143, or 105.35% from $1,323,405 for the three months ended

June 30, 2023.

The increase was mainly due to the increase in depreciation of idle fixed assets during production suspension.

Income (Loss) from Operations

Operating income for the quarter ended June 30,

2024 was $547,752, an increase of $1,066,435, or 205.60%, from loss from operations of $518,683 for the quarter ended June 30, 2023.

increase in income from operations was primarily due to the increase gross profit, partially offset by the increase in selling, general

and administrative expenses.

Other Income and Expenses

Interest expense for the three months ended March 31,

2024 decreased by $38,879, from $249,169 in the three months ended March 31, 2023, to $210,290.

Interest expense for the three months ended June

30, 2024 decreased by $91,941, from $270,681 in the three months ended June 30, 2023, to $178,740.

The Company had short-term and long-term

interest-bearing loans, related party loans and leasing obligations that aggregated $12,204,370 as of March 31, 2024, as compared to $18,212,347

as of March 31, 2023.

interest-bearing loans, related party loans and leasing obligations that aggregated $12,149,914 as of June 30, 2024, as compared to $17,607,943

as of June 30, 2023.

Gain on derivative liability

analyzed the warrant for derivative accounting consideration under ASC 815, “Derivatives and Hedging, and hedging,” and determined

that the instrument should be classified as a liability.

ASC 815 requires we assess the fair market value of derivative liability at the

end of each reporting period and recognize any change in the fair market value as other income or expense item.

The change in fair value

of derivative liability for the three months ended March 31, 2024 and 2023 was a gain of $34 and $152,097, respectively.

As a result and the factors discussed above, net loss

was $ 3,746,536 for the quarter ended March 31, 2024, representing a decrease of $1,013,371, or 37.08 %,

from $2,733,165 in net loss for the quarter ended March 31, 2023.

The Company analyzed the

warrant for derivative accounting consideration under ASC 815, “Derivatives and Hedging, and hedging,” and determined that

the instrument should be classified as a liability.

ASC 815 requires we assess the fair market value of derivative liability at the end

of each reporting period and recognize any change in the fair market value as other income or expense item.

The change in fair value of

derivative liability for the three months ended June 30, 2024 and 2023 was a gain of $15 and a loss of $166,506, respectively.

As a result and the factors discussed above, net

loss was $77,747 for the quarter ended June 30, 2024, representing a decrease of loss of $1,175,746, or 93.80%, from $1,253,493 for the

quarter ended June 30, 2023.

Comparison of the Six months ended June 30, 2024 and 2023

Revenue for the six months ended June 30, 2024

was $33,113,629, representing a decrease of $16,697,162, or 33.52%, from $49,810,791 for the same period in the previous year.

mainly due to the production suspension of CMP in January and February of 2024, and production suspension of offset printing paper and

tissue paper products in the first half of 2024.

Revenue of Offset Printing Paper, Corrugating Medium Paper and Tissue

Paper Products

Revenue from sales of offset printing paper, CMP and tissue paper products

for the six months ended June 30, 2024 was $33,039,615, a decrease of $16,687,267, or 33.56%, from $49,726,882 for the six months ended

June 30, 2023.

This was mainly due to the decrease in sales volume of CMP, offset printing paper and tissue paper products, and the decrease

in ASPs of CMP.

Total quantities of offset printing paper, CMP and tissue paper products sold during the six months ended June 30, 2024

amounted to 94,034 tonnes, a decrease of 34,475 tonnes, or 26.83%, compared to 128,509 tonnes sold during the six months ended June 30,

Total quantities of CMP and offset printing paper sold decreased by 33,991 tonnes in the six months of 2024 as compared to the same

period of 2023.

Production of CMP was suspended in January and February of 2024 and resumed in mid of March 2024, and production of offset

printing paper and tissue paper products was suspended in the first half of 2024 due to energy price rise and Chinese New Year holiday.

The production of offset printing paper and tissue paper products is expected to resume in the third quarter of 2024.

The changes in revenue

and quantity sold for the six months ended June 30, 2024 and 2023 are summarized as follows:

Six Months Ended

June 30, 2024

June 30, 2023

Sales Revenue

Quantity (Tonne)

Light-Weight CMP

Offset Printing Paper

Tissue Paper Products

Total CMP, Offset Printing Paper and Tissue Paper Revenue

ASPs for our main products in the six-month period ended June

30, 2024 and 2023 are summarized as follows:

Offset Printing

Light-Weight CMP ASP

Six Months Ended June 30, 2024

Six Months Ended June 30, 2023

Decrease from comparable period in the previous year

Decrease by percentage

Revenue of Face Masks

Revenue generated from selling face masks were $nil and $79,883 for

the six months ended June 30, 2024 and 2023.

Cost of Sales

Total cost of sales for CMP, offset printing paper and tissue paper

products in the six months ended June 30, 2024 was $29,448,953, a decrease of $19,361,616, or 39.67%, from $48,810,569 for the six months

ended June 30, 2023.

This was mainly due to the decrease in sales quantity and the decrease in the unit material costs of CMP.

Cost of sales for CMP was $29,448,953for the six months ended June

30, 2024, as compared to $43,747,945 in the same period of 2023.

The decrease in the cost of sales of $14,298,992 for CMP was mainly due

to the decreases in sales volume and average unit cost of sales of CMP.

Average cost of sales per tonne for CMP decreased by 12.32%, from

$357 for the six months ended June 30, 2023, to $313 in the same period of 2024.

This was mainly attributable to the lower average unit

purchase costs (net of applicable value added tax) of recycled paper board.

Cost of sales for offset printing paper was $nil for the six months

ended June 30, 2024, as compared to $3,079,485 in the same period of 2023.

Cost of sales for tissue paper products was $nil for the six months

ended June 30, 2024, as compared to $1,983,139 in the same period of 2023.

Changes in cost of sales and cost per tonne by product for the six

months ended June 30, 2024 and 2023 are summarized below:

Six Months Ended

June 30, 2024

June 30, 2023

Change in percentage

Cost of Sales

Cost per Tonne

Cost of Sales

Cost per tonne

Cost of Sales

Cost per Tonne

Cost of Sales

Cost per Tone

$ (11,867,147 )

Light-Weight CMP

$ (2,431,845 )

$ (14,298,992 )

Offset Printing Paper

$ (3,079,485 )

Tissue Paper Products

$ (1,983,139 )

Total CMP, Offset Printing Paper and Tissue Paper Revenue

$ (19,361,616 )

Gross profit for the six months ended June 30, 2024 was $3,664,413

(representing 11.07% of the total revenue), representing an increase of $2,761,554, or 305.87%, from the gross profit of $902,859 (representing

1.81% of the total revenue) for the six months ended June 30, 2023.

The increase was mainly due to the decrease in unit cost of materials

of CMP, partially offset by the decrease in ASP of CMP.

Offset Printing Paper, CMP and Tissue Paper Products

Gross profit for offset printing paper, CMP and

tissue paper products for the six months ended June 30, 2024 was $3,590,662, an increase of $2,674,349, or 291.86%, from the gross profit

of $916,313 for the six months ended June 30, 2023.

The increase was mainly the result of the factors discussed above.

The overall gross profit margin for offset printing paper, CMP and

tissue paper products increased by 9.03 percentage points, from 1.84% for the six months ended June 30, 2023, to 10.87% for the six months

ended June 30, 2024.

Gross profit margin for regular CMP for the six months ended June 30,

2024 was 10.86%, or 6.15 percentage points higher, as compared to gross profit margin of 4.71% for the six months ended June 30, 2023.

Such increase was primarily due to decrease in material costs, partially offset by the decrease in ASP of regular CMP.

Gross profit margin for light-weight CMP for the six months ended June

30, 2024 was 10.90%, or 5.04 percentage points higher, as compared to gross profit margin of 5.86% for the six months ended June 30, 2023.

Such increase was primarily due to the decrease in material costs, partially offset by the decrease in ASP of light-weight CMP.

Gross loss for face mask for the six months ended June 30, 2024 and

2023 was $nil and $6,407, respectively.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the six months ended

June 30, 2024 were $6,618,331, an increase of $2,799,564, or 73.31% from $3,818,767 for the six months ended June 30, 2023.

was mainly due to the increase in depreciation of idle fixed assets during production suspension.

Loss from Operations

Operating loss for the six months ended June 30, 2024 was $2,953,918,

a decrease of loss of $337,126, or 10.24%, from $3,291,044 for the six months ended June 30, 2023.

The decrease of loss was primarily

due to the increase in gross profit, partially offset by the increase in selling, general and administrative expenses.

Other Income and Expenses

Interest expense for the six months ended June 30, 2024 decreased by

$130,820, from $519,850 for the six months ended June 30, 2023, to $389,030.

The Company had short-term and long-term interest-bearing

loans and lease obligation that aggregated $12,149,914 as of June 30, 2024, as compared to $17,607,943 as of June 30, 2023.

Gain (Loss) on derivative liability

The Company analyzed the warrant for derivative accounting consideration

under ASC 815, “Derivatives and Hedging, and hedging,” and determined that the instrument should be classified as a liability.

ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change

in the fair market value as other income or expense item.

The change in fair value of derivative liability for the six months ended June

30, 2022 and 2023 was a gain of $49 and a loss of $14,409, respectively.

As a result of the above, net loss was $3,824,283 for the six months

ended June 30, 2024, representing a decrease of loss of $162,375, or 4.07%, from $3,986,658 for the six months ended June 30, 2023.

Accounts Receivable

Net accounts receivable increased by $1,810,651, or 314.61%,

to $2,386,177 as of March 31, 2024, as compared with $575,526 as of December 31, 2023.

We usually collect accounts receivable within 30

days of delivery and completion of sales.

Inventories consist of raw materials (accounting for

36.15% of total value of inventory as of March 31, 2024), semi-finished goods and finished goods.

As of March 31, 2024, the recorded value

of inventory decreased by 1.77% to $3,492,364 from $3,555,235 as of December 31, 2023.

As of March 31, 2024, the inventory of recycled

Net accounts receivable increased by $2,062,693,

or 358.40%, to $2,638,219 as of June 30, 2024, as compared with $575,526 as of December 31, 2023.

We usually collect accounts receivable

within 30 days of delivery and completion of sales.

Inventories consist of raw materials (accounting

for 70.41% of total value of inventory as of June 30, 2024), semi-finished goods and finished goods.

As of June 30, 2024, the recorded

value of inventory increased by 48.58% to $5,282,420 from $3,555,235 as of December 31, 2023.

As of June 30, 2024, the inventory of recycled

paper board, which is the main raw material for the production of CMP, was $3,462,147, approximately $3,263,403, or 1642.01%, higher than

7 unchanged sentences

Tissue base paper

Other raw materials

Mask fabric and other raw materials

Total Raw Materials

5 unchanged sentences

Renewal of operating lease

On August 7, 2013, the Company’s

Audit Committee and the Board of Directors approved the sale of the land use right of the Headquarters Compound (the “LUR”),

the office building and essentially all industrial-use buildings in the Headquarters Compound (the “Industrial Buildings”),

and three employee dormitory buildings located within the Headquarters Compound (the “Dormitories”) to Hebei Fangsheng for

cash prices of approximately $2.77 million, $1.15 million, and $4.31 million respectively.

In connection with the sale of the Industrial

Buildings, Hebei Fangsheng agreed to lease the Industrial Buildings back to the Company for its original use for a term of up to three

years, with an annual rental payment of approximately $140,829 (RMB1,000,000).

The lease agreement was renewed in August 2022 with a term

of six years with the same rental payments as provided for in the original lease agreement.

Capital Expenditure Commitment as of March 31, 2024

On May 5, 2020, the Company announced

it planned the commercial launch of a new tissue paper production line PM10 and the Company signed an agreement to purchase paper machine

with paper machine supplier.

On August 7, 2013, the Company’s Audit Committee

and the Board of Directors approved the sale of the land use right of the Headquarters Compound (the “LUR”), the office building

and essentially all industrial-use buildings in the Headquarters Compound (the “Industrial Buildings”), and three employee

dormitory buildings located within the Headquarters Compound (the “Dormitories”) to Hebei Fangsheng for cash prices of approximately

$2.77 million, $1.15 million, and $4.31 million respectively.

In connection with the sale of the Industrial Buildings, Hebei Fangsheng

agreed to lease the Industrial Buildings back to the Company for its original use for a term of up to three years, with an annual rental

payment of approximately $140,698 (RMB1,000,000).

The lease agreement was renewed in August 2022 with a term of six years with the same

rental payments as provided for in the original lease agreement.

Capital Expenditure Commitment as of June 30, 2024

On May 5, 2020, the Company announced it planned

the commercial launch of a new tissue paper production line PM10 and the Company signed an agreement to purchase paper machine with paper

machine supplier.

The Company expected the new tissue paper production line to be launched after the completion of trial run.

As of March 31, 2024, we had approximately

As of June 30, 2024, we had approximately $3.5

million in capital expenditure commitments that were mainly related to the purchase of paper machine of PM10.

The infrastructure

work of PM10 has been completed and the associated ancillary facilities are working in progress.

These commitments are expected to be

financed by bank loans and cash flows generated from our business operations.

The infrastructure work

of PM10 is complete, while work on the related ancillary facilities is ongoing.

These commitments are expected to be financed by bank

loans and cash flows generated from our business operations.

Financing with Sale-Leaseback

The Company entered into a sale-leaseback

arrangement (the “Lease Financing Agreement”) with TAC Leasing Co., Ltd.(“TLCL”) on August 6, 2020, for a total

financing proceeds in the amount of RMB 16 million (approximately US$2.3 million).

Under the sale-leaseback arrangement, Tengsheng Paper

sold the Leased Equipment to TLCL for 16 million (approximately US$2.3 million).

Concurrent with the sale of equipment, Tengsheng Paper

leases back the equipment sold to TLCL for a lease term of three years.

At the end of the lease term, Tengsheng Paper may pay a nominal

purchase price of RMB 100 (approximately $14) to TLCL and buy back the Leased Equipment.

The Leased Equipment in amount of $2,349,452

was recorded as right of use assets and the net present value of the minimum lease payments was recorded as lease liability and calculated

with TLCL’s implicit interest rate of 15.6% per annum and stated at $567,099 at the inception of the lease on August 17, 2020.

Tengsheng Paper made payments due

according to the schedule.

On July 17, 2023, the Company made a final payment on outstanding obligations and bought back the Lease Equipment

at nominal price according to the agreement.

The Company entered into a sale-leaseback arrangement

(the “Lease Financing Agreement”) with TAC Leasing Co., Ltd.(“TLCL”) on August 6, 2020, for a total financing

proceeds in the amount of RMB 16 million (approximately US$2.3 million).

Under the sale-leaseback arrangement, Tengsheng Paper sold the

Leased Equipment to TLCL for 16 million (approximately US$2.3 million).

Concurrent with the sale of equipment, Tengsheng Paper leases

back the equipment sold to TLCL for a lease term of three years.

At the end of the lease term, Tengsheng Paper may pay a nominal purchase

price of RMB 100 (approximately $14) to TLCL and buy back the Leased Equipment.

The Leased Equipment in amount of $2,349,452 was recorded

as right of use assets and the net present value of the minimum lease payments was recorded as lease liability and calculated with TLCL’s

implicit interest rate of 15.6% per annum and stated at $567,099 at the inception of the lease on August 17, 2020.

Tengsheng Paper made payments due according to

the schedule.

On July 17, 2023, the Company made a final payment on outstanding obligations and bought back the Lease Equipment at nominal

price according to the agreement.

The lease assets were reclassified as own assets and balance of Leased Equipment net of amortization

were $nil as of March 31, 2024 and December 31, 2023.

were $nil as of June 30, 2024 and December 31, 2023.

Cash and Cash Equivalents

Our cash, cash equivalents and restricted cash as of March

31, 2024 was $5,417,560, an increase of $1,025,639, from $4,391,921 as of December 31, 2023.

The increase of cash and cash equivalents

for the three months ended March 31, 2024 was attributable to a number of factors including:

Net cash provided by (used in) operating activities

Our cash, cash equivalents and restricted cash

as of June 30, 2024 was $6,043,922, an increase of $1,652,001, from $4,391,921 as of December 31, 2023.

The increase of cash and cash

equivalents for the six months ended June 30, 2024 was attributable to a number of factors including:

Net cash provided by operating activities

was $624,420 for the three months ended March 31, 2024.

Net cash provided by operating activities was

$1,346,337 for the six months ended June 30, 2024.

The balance represented a decrease of cash of $4,400,382, or 76.57%, from $5,746,719

provided for the three months ended March 31, 2023.

Net loss for the three months ended March 31, 2024 was $ 3,746,536 ,

representing a decrease of $ 1,013,371 , or 37.08%, from a net loss of $2,733,165 for the three months

ended March 31, 2023.

Changes in various asset and liability account balances throughout the three months ended March 31, 2024 also contributed

to the net change in cash from operating activities in three months ended March 31, 2024.

Chief among such changes is the increase of

accounts receivable in the amount of $1,847,112 during the three months of 2024.

There was also a decrease of $59,612 in the ending inventory

balance as of March 31, 2024 (an increase to net cash for the three months ended March 31, 2024 cash flow purposes).

In addition, the

Company had non-cash expenses relating to depreciation and amortization in the amount of $3,481,788.

The Company also had a net decrease

of $ 1,276,805 in prepayment and other current assets (an increase to net cash) and a net increase

of $ 908,127 in other payables and accrued liabilities and related parties (an increase to net cash)

during the three months ended March 31, 2024.

provided for the six months ended June 30, 2023.

Net loss for the six months ended June 30, 2024 was $3,824,283, representing a decrease

of loss of $162,375, or 4.07%, from $3,986,658 for the six months ended June 30, 2023.

Changes in various asset and liability account

balances throughout the six months ended June 30, 2024 also contributed to the net change in cash from operating activities in six months

ended June 30, 2024.

Chief among such changes is the increase of accounts receivable in the amount of $2,121,357 during the six months

There was also an increase of $1,751,011 in the ending inventory balance as of June 30, 2024 (a decrease to net cash for the

six months ended June 30, 2024 cash flow purposes).

In addition, the Company had non-cash expenses relating to depreciation and amortization

in the amount of $6,862,883.

The Company also had a net decrease of $660,470 in prepayment and other current assets (an increase to net

cash) and a net increase of $692,857 in other payables and accrued liabilities and related parties (an increase to net cash), as well

as an increase in income tax payable of $416,770 (an increase to net cash) during the six months ended June 30, 2024.

Net cash used in investing activities

We incurred $9,027 in net cash expenditures for investing

activities during the three months ended March 31, 2024, as compared to $295,018 for the same period of 2023.

Net cash provided by financing activities

We incurred $62,640 in net cash expenditures for

investing activities during the six months ended June 30, 2024, as compared to $5,565,713 for the same period of 2023.

Net cash provided by financing activities

was $422,488 for the three months ended March 31, 2024, as compared to net cash provided by financing activities in the amount of $2,564,646

for the three months ended March 31, 2023.

Net cash provided by financing activities was

$422,096 for the six months ended June 30, 2024, as compared to net cash provided by financing activities in the amount of $2,823,597

for the six months ended June 30, 2023.

Short-term bank loans

3 unchanged sentences

Total short-term bank loans

On December 31, 2023, the Company

entered into a working capital loan agreement with the Bank of Cangzhou, to borrow $140,944 at a fixed interest rate of 5.5% per annum.

The loan is secured by certain of the Company’s manufacturing equipment with net book value of $306,528 as of March 31, 2024.

loan will be due by December 30, 2024.

On December 31, 2023, the Company

entered into a working capital loan agreement with the Bank of Cangzhou, to borrow $281,889 at a fixed interest rate of 5.5% per annum.

The loan will be due by December 30, 2024.

On September 15, 2023, the Company

entered into a working capital loan agreement with the ICBC, with a balance of $2,819 and $2,824 as of March 31, 2024 and December 31,

2023, respectively.

The loan bears a fixed interest rate of 3.45% per annum.

The loan will be due by September 14, 2024.

On September 22, 2023, the Company

entered into a working capital loan agreement with the ICBC, with a balance of $70,472 and $70,594 as of March 31, 2024 and December 31,

2023, respectively.

The loan bears a fixed interest rate of 3.45% per annum.

The loan will be due by September 21, 2024.

On September 22, 2023, the Company

entered into a working capital loan agreement with the ICBC, with a balance of $349,542 and $350,149 as of March 31, 2024 and December

31, 2023, respectively.

The loan bears a fixed interest rate of 3.45% per annum.

The loan will be due by September 21, 2024.

As of March 31, 2024, there were

guaranteed short-term borrowings of $nil and unsecured bank loans of $704,722.

As of December 31, 2023, there were guaranteed short-term

On December 31, 2023, the Company entered into

a working capital loan agreement with the Bank of Cangzhou, to borrow $140,315 at a fixed interest rate of 5.5% per annum.

secured by certain of the Company’s manufacturing equipment with net book value of $276,269 as of June 30, 2024.

The loan will be

due by December 30, 2024.

On December 31, 2023, the Company entered into

a working capital loan agreement with the Bank of Cangzhou, to borrow $280,631 at a fixed interest rate of 5.5% per annum.

The loan will

be due by December 30, 2024.

On September 15, 2023, the Company entered into

a working capital loan agreement with the ICBC, with a balance of $nil and $2,824 as of June 30, 2024 and December 31, 2023, respectively.

The loan bore a fixed interest rate of 3.45% per annum.

The loan was repaid in June 2024.

On September 22, 2023, the Company entered into

a working capital loan agreement with the ICBC, with a balance of $nil and $70,594 as of June 30, 2024 and December 31, 2023, respectively.

The loan bore a fixed interest rate of 3.45% per annum.

The loan was repaid in June 2024.

On September 22, 2023, the Company entered into

a working capital loan agreement with the ICBC, with a balance of $nil and $350,149 as of June 30, 2024 and December 31, 2023, respectively.

The loan bore a fixed interest rate of 3.45% per annum.

The loan was repaid in June 2024.

On June 11, 2024, the Company entered into a working

capital loan agreement with the ICBC, with a balance of $2,806 as of June 30, 2024.

The loan bears a fixed interest rate of 3.45% per

The loan will be due by June 11, 2025.

On June 21, 2024, the Company entered into a working

capital loan agreement with the ICBC, with a balance of $140,316 as of June 30, 2024.

The loan bears a fixed interest rate of 3.45% per

The loan will be due by June 21, 2025.

On June 22, 2024, the Company entered into a working

capital loan agreement with the ICBC, with a balance of $140,316 as of June 30, 2024.

The loan bears a fixed interest rate of 3.45% per

The loan will be due by June 22, 2025.

On June 24, 2024, the Company entered into a working

capital loan agreement with the ICBC, with a balance of $137,509 as of June 30, 2024.

The loan bears a fixed interest rate of 3.45% per

The loan will be due by June 24, 2025.

As of June 30, 2024, there were guaranteed short-term

borrowings of $nil and unsecured bank loans of $701,577.

The average short-term borrowing

rates for the three months ended March 31, 2024 and 2023 were approximately 4.48% and 4.72%.

As of December 31, 2023, there were guaranteed short-term borrowings of $nil

and unsecured bank loans of $423,567.

The average short-term borrowing rates for the

three months ended June 30, 2024 and 2023 were approximately 4.45% and 4.83%.

The average short-term borrowing rates for the six months

ended June 30, 2024 and 2023 were approximately 4.46% and 4.77%.

Long-term loans

As of March 31, 2024 and December 31, 2023, long-term loans

were $11,358,704 and $11,378,429, respectively.

On July 15, 2013, the Company entered

into a loan agreement with the Rural Credit Union of Xushui District for a term of 5 years, which was originally due and payable in various

installments from December 21, 2013 to July 26, 2018.

On June 21, 2018, the loan was extended for additional 5 years and was due and payable

in various installments from December 21, 2018 to June 20, 2023.

On August 24, 2023, the loan was extended for another 3 years and will

be due and payable on August 24, 2026.

The loan is secured by certain of the Company’s manufacturing equipment with net book value

of $nil as of March 31, 2024 and December 31, 2023.

As of June 30, 2024 and December 31, 2023, long-term loans were $ 11,308,021

and $11,378,429, respectively.

On July 15, 2013, the Company entered into a loan agreement with

the Rural Credit Union of Xushui District for a term of 5 years, which was originally due and payable in various installments from December

21, 2013 to July 26, 2018.

On June 21, 2018, the loan was extended for additional 5 years and was due and payable in various installments

from December 21, 2018 to June 20, 2023.

On August 24, 2023, the loan was extended for another 3 years and will be due and payable on

August 24, 2026.

The loan is secured by certain of the Company’s manufacturing equipment with net book value of $nil as of June

30, 2024 and December 31, 2023.

Interest payment is due monthly and bore a rate of 7.68% per annum.

Effective from

November 15, 2022, the interest rate was reduced to 7% per annum.

As of March 31, 2024 and December 31, 2023, the total outstanding loan

balance was $3,522,200 and $3,528,315.

Out of the total outstanding loan balance, current portion amounted was $1,267,090 and $1,269,290,

which is presented as current liabilities in the consolidated balance sheet and the remaining balance of $2,255,110 and $2,259,025 is

presented as non-current liabilities in the consolidated balance sheet as of March 31, 2024 and December 31, 2023, respectively.

On April 17, 2019, the Company entered

into a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which was due and payable in various installments

Effective from November 15, 2022,

the interest rate was reduced to 7% per annum.

As of June 30, 2024 and December 31, 2023, the total outstanding loan balance was $3,506,482

and $3,528,315.

Out of the total outstanding loan balance, current portion amounted was $1,963,012 and $1,269,290, which is presented

as current liabilities in the consolidated balance sheet and the remaining balance of $1,543,470 and $2,259,025 is presented as non-current

liabilities in the consolidated balance sheet as of June 30, 2024 and December 31, 2023, respectively.

On April 17, 2019, the Company entered into a

loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which was due and payable in various installments

from August 21, 2019 to April 16, 2021.

The loan was renewed on March 22, 2021 and December 24, 2021 and extended for additional 3 years

in total, which will be due on April 16, 2024 according to the new schedule.

The loan is secured by Tengsheng Paper with its land use

right as collateral for the benefit of the credit union.

The loan was renewed on March 22, 2021, December 24, 2021 and April 16, 2024 and extended for

additional 5 years in total, which is due on April 15, 2026 according to the new schedule.

The loan is secured by Tengsheng Paper with

its land use right as collateral for the benefit of the credit union.

Interest payment is due quarterly and bore a rate of 7.68% per annum.

from November 15, 2022, the interest rate was reduced to 7% per annum.

As of March 31, 2024 and December 31, 2023, the total outstanding

loan balance was $2,255,109 and $2,259,026, respectively, which are presented as current liabilities in the consolidated balance sheet

as of March 31, 2024 and December 31, 2023.

On December 12, 2019, the Company entered

into a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which is due and payable in various installments

Effective from November 15, 2022, the interest rate was reduced to 7% per annum.

As of June 30, 2024 and December 31, 2023, the total

outstanding loan balance was $2,245,047 and $2,259,026, respectively, which are presented as non- current liabilities and current liabilities,

respectively, in the consolidated balance sheet as of June 30, 2024 and December 31, 2023.

On December 12, 2019, the Company entered into

a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which is due and payable in various installments

from June 21, 2020 to December 11, 2021.

5 unchanged sentences

from November 15, 2022, the interest rate was reduced to 7% per annum.

As of March 31, 2024 and December 31, 2023, the total outstanding

As of June 30, 2024 and December 31, 2023, the total outstanding

loan balance was $1,824,101 and $1,835,458, respectively, which are presented as current liabilities in the consolidated balance sheet

as of March 31, 2024 and December 31, 2023.

On February 26, 2023, the Company entered

into a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which is due and payable in various installments

as of June 30, 2024 and December 31, 2023.

On February 26, 2023, the Company entered into

a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which is due and payable in various installments

from August 21, 2023 to February 24, 2025.

2 unchanged sentences

Interest payment is due monthly and bore a rate of 7% per annum.

As of March 31, 2024 and December 31, 2023, the

total outstanding loan balance was $2,536,998 and $2,541,404.

As of June 30, 2024 and December 31, 2023, the total

outstanding loan balance was $2,525,678 and $2,541,404.

Out of the total outstanding loan balance, current portion amounted was $2,525,678

$2,536,998 and $1,284,820, which is presented as current liabilities in the consolidated balance sheet and the remaining balance of $nil

and $1,256,584 is presented as non-current liabilities in the consolidated balance sheet as of March 31, 2024 and December 31, 2023, respectively.

On December 5, 2023, the Company entered

into a loan agreement with the Rural Credit Union of Xushui District for a term of 3 years, which was due in various installments from

June 21, 2024 to December 5, 2026.

and $1,284,820, which is presented as current liabilities in the consolidated balance sheet and the remaining balance of $nil and $1,256,584

is presented as non-current liabilities in the consolidated balance sheet as of June 30, 2024 and December 31, 2023, respectively.

loan was fully repaid in July 2024.

On December 5, 2023, the Company entered into

a loan agreement with the Rural Credit Union of Xushui District for a term of 3 years, which was due in various installments from June

21, 2024 to December 5, 2026.

The loan was guaranteed by an independent third party.

Interest payment was due monthly and bore a

rate of 7% per annum.

As of March 31, 2024 and December 31, 2023, total outstanding loan balance was $1,212,121 and $1,214,226, respectively.

Interest payment was due monthly and bore a rate

of 7% per annum.

As of June 30, 2024 and December 31, 2023, total outstanding loan balance was $1,206,713 and $1,214,226, respectively.

Out of the total outstanding loan balance, current portion amounted $505,136 and $225,903, which is presented as current liabilities and

the remaining balance of $986,610 and $988,323 is presented as non-current liabilities in the consolidated balance sheet as of March 31,

the remaining balance of $701,577 and $988,323 is presented as non-current liabilities in the consolidated balance sheet as of June 30,

2024 and December 31, 2023, respectively.

Total interest expenses for the short-term bank loans and long-term

loans for the three months ended June 30, 2024 and 2023 were $211,551 and $268,499, respectively.

Total interest expenses for the short-term

bank loans and long-term loans for the three months ended March 31, 2024 and 2023 were $209,586 and $244,679, respectively.

bank loans and long-term loans for the six months ended June 30, 2024 and 2023 were $421,841 and $513,179, respectively.

Shareholder Loans

Zhenyong Liu, the Company’s

CEO has loaned money to Dongfang Paper for working capital purposes over a period of time.

Zhenyong Liu, the Company’s CEO has

loaned money to Dongfang Paper for working capital purposes over a period of time.

On January 1, 2013,Dongfang Paper and Mr.

3 unchanged sentences

Zhenyong Liu, which were recorded in other payables and accrued

liabilities as part of the current liabilities in the consolidated balance sheet as of March 31, 2024 and December 31, 2023, respectively.

liabilities as part of the current liabilities in the consolidated balance sheet as of June 30, 2024 and December 31, 2023, respectively.

On December 10, 2014, Mr.

Liu provided a loan to the Company, amounted to $8,742,278 to Dongfang Paper for working capital purpose with an interest rate of 4.35%

per annum, which was based on the primary lending rate of People’s Bank of China.

The unsecured loan was provided on December 10,

2014, and would be originally due on December 10, 2017.

Zhenyong Liu provided

a loan to the Company, amounted to $8,742,278 to Dongfang Paper for working capital purpose with an interest rate of 4.35% per annum,

which was based on the primary lending rate of People’s Bank of China.

The unsecured loan was provided on December 10, 2014, and

would be originally due on December 10, 2017.

During the year of 2016, the Company repaid $6,012,416 to Mr.

Zhenyong Liu, together

with interest of $288,596.

Zhenyong Liu, together with

interest of $288,596.

In February 2018, the Company paid off the remaining balance, together with interest of $20,400.

As of June 30,

2024 and December 31, 2023, approximately $42,095 and $42,357 of interest, respectively, were outstanding to Mr.

Zhenyong Liu, which

was recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet.

On March 1, 2015, the Company entered

an agreement with Mr.

Zhenyong Liu which allows Dongfang Paper to borrow from the CEO an amount up to $17,201,342 (RMB120,000,000) for

working capital purposes.

Zhenyong Liu, which was

recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet.

On March 1, 2015, the Company entered an agreement

Zhenyong Liu which allows Dongfang Paper to borrow from the CEO an amount up to $17,201,342 (RMB120,000,000) for working capital

The advances or funding under the agreement are due three years from the date each amount is funded.

is unsecured and carries an annual interest rate set on the basis of the primary lending rate of the People’s Bank of China at the

time of the borrowing.

The loan is unsecured and

carries an annual interest rate set on the basis of the primary lending rate of the People’s Bank of China at the time of the borrowing.

On July 13, 2015, an unsecured amount of $4,324,636 was drawn from the facility.

On October 14, 2016 an unsecured

amount of $2,883,091 was drawn from the facility.

On October 14, 2016 an unsecured amount of $2,883,091

was drawn from the facility.

In February 2018, the Company repaid $1,507,432 to Mr.

Zhenyong Liu.

The loan would

be originally due on July 12, 2018.

Zhenyong Liu agreed to extend the loan for additional 3 years and the remaining balance will be

due on July 12, 2021.

The loan would be originally due on

July 12, 2018.

Zhenyong Liu agreed to extend the loan for additional 3 years and the remaining balance will be due on July 12, 2021.

On November 23, 2018, the company repaid $3,768,579 to Mr.

Zhenyong Liu, together with interest of $158,651.

December 2019, the company paid off the remaining balance, together with interest of 94,636.

As of March 31, 2024 and December 31, 2023,

the outstanding interest was $193,710 and $194,047, respectively, which was recorded in other payables and accrued liabilities as part

of the current liabilities in the consolidated balance sheet.

As of March 31, 2024 and December

31, 2023, total amount of loans due to Mr.

In December 2019, the company

paid off the remaining balance, together with interest of 94,636.

As of June 30, 2024 and December 31, 2023, the outstanding interest

was $192,846 and $194,047, respectively, which was recorded in other payables and accrued liabilities as part of the current liabilities

in the consolidated balance sheet.

As of June 30, 2024 and December 31, 2023, total

amount of loans due to Mr.

Zhenyong Liu were $nil.

The interest expense incurred for such related party loans were $nil

for the three months ended March 31, 2024 and 2023.

The interest expense incurred for such related party loans were $nil for the three

and six months ended June 30, 2024 and 2023.

The accrued interest owing to Mr.

Zhenyong Liu was approximately $597,282 and $598,319,

as of March 31, 2024 and December 31, 2023, respectively, which was recorded in other payables and accrued liabilities.

Critical Accounting Policies and

The Company’s financial statements

are prepared in accordance with accounting principles generally accepted in the United States, which require us to make estimates and

assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date

of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Management makes these estimates

using the best information available at the time the estimates are made.

Zhenyong Liu was approximately $594,617 and $598,319, as

of June 30, 2024 and December 31, 2023, respectively, which was recorded in other payables and accrued liabilities.

Zhenyong Liu,

the Company’s CEO has loaned money to Dongfang Paper for working capital purposes over a period of time.

On January 1, 2013,Dongfang

Paper and Mr.

Zhenyong Liu renewed the three-year term loan previously entered on January 1, 2010, and extended the maturity date further

to December 31, 2015.

On December 31, 2015, the Company paid off the loan of $2,249,279, together with interest of $391,374 for the period

from 2013 to 2015.

Approximately $359,676 and $361,915 of interest were outstanding to Mr.

Zhenyong Liu, which were recorded in other

payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet as of June 30, 2024 and December

31, 2023, respectively.

On December 10, 2014, Mr.

Zhenyong Liu provided

a loan to the Company, amounted to $8,742,278 to Dongfang Paper for working capital purpose with an interest rate of 4.35% per annum,

which was based on the primary lending rate of People’s Bank of China.

The unsecured loan was provided on December 10, 2014, and

would be originally due on December 10, 2017.

During the year of 2016, the Company repaid $6,012,416 to Mr.

Zhenyong Liu, together with

interest of $288,596.

In February 2018, the Company paid off the remaining balance, together with interest of $20,400.

As of June 30,

2024 and December 31, 2023, approximately $42,095 and $42,357 of interest, respectively, were outstanding to Mr.

Zhenyong Liu, which was

recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet.

On March 1, 2015, the Company entered an agreement

Zhenyong Liu which allows Dongfang Paper to borrow from the CEO an amount up to $17,201,342 (RMB120,000,000) for working capital

The advances or funding under the agreement are due three years from the date each amount is funded.

The loan is unsecured and

carries an annual interest rate set on the basis of the primary lending rate of the People’s Bank of China at the time of the borrowing.

On July 13, 2015, an unsecured amount of $4,324,636 was drawn from the facility.

On October 14, 2016 an unsecured amount of $2,883,091

was drawn from the facility.

In February 2018, the Company repaid $1,507,432 to Mr.

Zhenyong Liu.

The loan would be originally due on

July 12, 2018.

Zhenyong Liu agreed to extend the loan for additional 3 years and the remaining balance will be due on July 12, 2021.

On November 23, 2018, the company repaid $3,768,579 to Mr.

Zhenyong Liu, together with interest of $158,651.

In December 2019, the company

paid off the remaining balance, together with interest of 94,636.

As of June 30, 2024 and December 31, 2023, the outstanding interest

was $192,846 and $194,047, respectively, which was recorded in other payables and accrued liabilities as part of the current liabilities

in the consolidated balance sheet.

As of June 30, 2024 and December 31, 2023, total

amount of loans due to Mr.

Zhenyong Liu were $nil.

The interest expense incurred for such related party loans were $nil for the three

and six months ended June 30, 2024 and 2023.

The accrued interest owing to Mr.

Zhenyong Liu was approximately $594,617 and $598,319, as

of June 30, 2024 and December 31, 2023, respectively, which was recorded in other payables and accrued liabilities.

Zhenyong Liu,

the Company’s CEO has loaned money to Dongfang Paper for working capital purposes over a period of time.

On January 1, 2013,Dongfang

Paper and Mr.

Zhenyong Liu renewed the three-year term loan previously entered on January 1, 2010, and extended the maturity date further

to December 31, 2015.

On December 31, 2015, the Company paid off the loan of $2,249,279, together with interest of $391,374 for the period

from 2013 to 2015.

Approximately $359,676 and $361,915 of interest were outstanding to Mr.

Zhenyong Liu, which were recorded in other

payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet as of June 30, 2024 and December

31, 2023, respectively.

On December 10, 2014, Mr.

Zhenyong Liu provided

a loan to the Company, amounted to $8,742,278 to Dongfang Paper for working capital purpose with an interest rate of 4.35% per annum,

which was based on the primary lending rate of People’s Bank of China.

The unsecured loan was provided on December 10, 2014, and

would be originally due on December 10, 2017.

During the year of 2016, the Company repaid $6,012,416 to Mr.

Zhenyong Liu, together with

interest of $288,596.

In February 2018, the Company paid off the remaining balance, together with interest of $20,400.

As of June 30,

2024 and December 31, 2023, approximately $42,095 and $42,357 of interest, respectively, were outstanding to Mr.

Zhenyong Liu, which was

recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet.

On March 1, 2015, the Company entered an agreement

Zhenyong Liu which allows Dongfang Paper to borrow from the CEO an amount up to $17,201,342 (RMB120,000,000) for working capital

The advances or funding under the agreement are due three years from the date each amount is funded.

The loan is unsecured and

carries an annual interest rate set on the basis of the primary lending rate of the People’s Bank of China at the time of the borrowing.

On July 13, 2015, an unsecured amount of $4,324,636 was drawn from the facility.

On October 14, 2016 an unsecured amount of $2,883,091

was drawn from the facility.

In February 2018, the Company repaid $1,507,432 to Mr.

Zhenyong Liu.

The loan would be originally due on

July 12, 2018.

Zhenyong Liu agreed to extend the loan for additional 3 years and the remaining balance will be due on July 12, 2021.

On November 23, 2018, the company repaid $3,768,579 to Mr.

Zhenyong Liu, together with interest of $158,651.

In December 2019, the company

paid off the remaining balance, together with interest of 94,636.

As of June 30, 2024 and December 31, 2023, the outstanding interest

was $192,846 and $194,047, respectively, which was recorded in other payables and accrued liabilities as part of the current liabilities

in the consolidated balance sheet.

As of June 30, 2024 and December 31, 2023, total

amount of loans due to Mr.

Zhenyong Liu were $nil.

The interest expense incurred for such related party loans were $nil for the three

and six months ended June 30, 2024 and 2023.

The accrued interest owing to Mr.

Zhenyong Liu was approximately $594,617 and $598,319, as

of June 30, 2024 and December 31, 2023, respectively, which was recorded in other payables and accrued liabilities.

In October 2022 and November 2022, the Company

entered into two agreements with Mr.

Zhenyong Liu, which allowed Mr.

Zhenyong Liu to borrow from the Company an amount of $7,059,455 (RMB50,000,000)

The loans were unsecured and carried a fixed interest rate of 4.35% per annum.

$4,235,673 (RMB30,000,000) was repaid by Mr.

Zhengyong Liu in August 2023 and the remaining balance was repaid in December 2023.

Interest income of the loan for the six months ended

June 30, 2024 and 2023 were $nil and $176,847.

As of June 30, 2024 and December 31, 2023, amount

due to shareholder was $727,433, which represents funds from shareholders to pay for various expenses incurred in the U.S.

is due on demand with interest free.

Critical Accounting Policies and Estimates

The Company’s financial statements are prepared

in accordance with accounting principles generally accepted in the United States, which require us to make estimates and assumptions that

affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial

statements and the reported amounts of revenues and expenses during the reporting periods.

Management makes these estimates using the

best information available at the time the estimates are made.

However, actual results could differ materially from those estimates.

The most critical accounting policies are listed below:

most critical accounting policies are listed below:

Revenue Recognition Policy

The Company recognizes revenue

when goods are delivered and a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant

obligations of the Company exist, and collectability is reasonably assured.

Goods are considered delivered when the customer’s truck

picks up goods at our finished goods inventory warehouse.

The Company recognizes revenue when goods are

delivered and a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant obligations

of the Company exist, and collectability is reasonably assured.

Goods are considered delivered when the customer’s truck picks up

goods at our finished goods inventory warehouse.

Long-Lived Assets

The Company evaluates the recoverability

of long-lived assets and the related estimated remaining useful lives when events or circumstances lead management to believe that the

carrying value of an asset may not be recoverable and the undiscounted cash flows estimated to be generated by those assets are less than

the assets’ carrying amount.

The Company evaluates the recoverability of long-lived

assets and the related estimated remaining useful lives when events or circumstances lead management to believe that the carrying value

of an asset may not be recoverable and the undiscounted cash flows estimated to be generated by those assets are less than the assets’

carrying amount.

In such circumstances, those assets are written down to estimated fair value.

Our judgments regarding

the existence of impairment indicators are based on market conditions, assumptions for operational performance of our businesses, and

possible government policy toward operating efficiency of the Chinese paper manufacturing industry.

For the three months ended March 31,

2024 and 2023, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.

are currently not aware of any events or circumstances that may indicate any need to record such impairment in the future.

Our judgments regarding the existence of

impairment indicators are based on market conditions, assumptions for operational performance of our businesses, and possible government

policy toward operating efficiency of the Chinese paper manufacturing industry.

For the six months ended June 30, 2024 and 2023, no events

or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.

We are currently not aware

of any events or circumstances that may indicate any need to record such impairment in the future.

Foreign Currency Translation

The functional currency of Dongfang

Paper and Baoding Shengde is the Chinese Yuan Renminbi (“RMB”).

Under ASC Topic 830-30, all assets and liabilities are translated

into United States dollars using the current exchange rate at the end of each fiscal period.

The functional currency of Dongfang Paper and

Baoding Shengde is the Chinese Yuan Renminbi (“RMB”).

Under ASC Topic 830-30, all assets and liabilities are translated into

United States dollars using the current exchange rate at the end of each fiscal period.

The current exchange rates used by the Company

as of March 31, 2024 and December 31, 2023 to translate the Chinese RMB to the U.S.

as of June 30, 2024 and December 31, 2023 to translate the Chinese RMB to the U.S.

Dollars are 7.1268:1 and 7.0827:1, respectively.

and expenses are translated using the prevailing average exchange rates at 7.1008:1 and 6.8613:1 for the three months ended March 31,

and expenses are translated using the prevailing average exchange rates at 7.1074:1 and 6.9693:1 for the six months ended June 30, 2024

and 2023, respectively.

1 unchanged sentence

Off-Balance Sheet Arrangements

We were the guarantor for Baoding

Huanrun Trading Co., for its long-term bank loans in an amount of $4,369,274 (RMB31,000,000), which matures at various times in 2028.

Baoding Huanrun Trading Co.

We were the guarantor for Baoding Huanrun Trading

Co., for its long-term bank loans in an amount of $4,349,778 (RMB31,000,000), which matures at various times in 2028.

Baoding Huanrun

is one of our major suppliers of raw materials.

This helps us to maintain a good relationship with the supplier

and negotiate for better terms in payment for materials.

This helps us to maintain a good relationship with the supplier and negotiate

for better terms in payment for materials.

If Huanrun Trading Co.

were to become insolvent, the Company could be materially

adversely affected.

were to become insolvent, the Company could be materially adversely

Except as aforesaid, we have no material off-balance sheet transactions.

Recent Accounting Pronouncements

In October 2021, the FASB issued

In October 2021, the FASB issued ASU No.

Business Combinations (Topic 805):

Accounting for Contract Assets and Contract Liabilities from Contracts with Customers

(ASU 2021-08), which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in

a business combination in accordance with Topic 606, Revenue from Contracts with Customers.

The new amendments are effective for fiscal

years beginning after December 15, 2023, including interim periods within those fiscal years.

The amendments should be applied prospectively

to business combinations occurring on or after the effective date of the amendments, with early adoption permitted.

The Company does not

expect the adoption of this standard to have a material impact on its consolidated financial statements.

Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (ASU 2021-08),

which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination

in accordance with Topic 606, Revenue from Contracts with Customers.

The new amendments are effective for fiscal years beginning after

December 15, 2023, including interim periods within those fiscal years.

The amendments should be applied prospectively to business combinations

occurring on or after the effective date of the amendments, with early adoption permitted.

The Company does not expect the adoption of

this standard to have a material impact on its consolidated financial statements.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis